A Prospective, Observational Study of Patients With Cervical Dystonia (Dystonie) Treated With OnabotulinumtoxinA

Allergan

Status: Completed

Conditions: Torticollis

Treatments: Biological: OnabotulinumtoxinA

Study type: Observational

Funder types: Industry

Identifiers

NCT01655862

CMA-BTX-12-001

Details and patient eligibility

About

This is an observational study to assess health-related quality of life in patients with cervical dystonia (dystonie) treated with OnabotulinumtoxinA per routine clinical practice.

Enrollment: 62 patients

Sex: All

Ages: 16+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosis of cervical dystonia (dystonie) and able to receive botulinum toxin Type A as deemed medically necessary by the physician

Exclusion criteria

• Participation in a clinical trial for any botulinum toxin indication
• Planning elective surgery during the observational study period
• Treatment with any botulinum toxin product for cervical dystonia (dystonie)
• Treatment with any botulinum toxin product for a non-cervical dystonia (dystonie) condition within 2 months of study start

Trial design

62 participants in 1 patient group

OnabotulinumtoxinA

Description:

OnabotulinumtoxinA injections at doses and frequencies as determined by the physician in accordance with clinical practice.

Treatment:

Biological: OnabotulinumtoxinA